Potential Anatomic and Functional Advantages of Using Pneumatic Retinopexy or Vitrectomy To Repair Macula-Involving Retinal Detachment

Potential Anatomic and Functional Advantages of Using Pneumatic Retinopexy or Vitrectomy To Repair MaculaInvolving Retinal De

Much has been written about rhegmatogenous retinal detachment and single surgery success rates. The decision of which procedure to choose is most often framed in terms of anatomic success, with less attention paid to how functional outcomes might be affected by this choice. In 2019, Hillier et al. published the PIVOT trial, a well-designed prospective randomized control trial comparing pneumatic retinopexy to vitrectomy for primary rhegmatogenous retinal detachment repair. One of the most striking findings (other than the high success rate of pneumatic performed by this group) was patients in the pneumatic retinopexy arm achieved better visual acuity and less vertical metamorphopsia at 1 year compared to those who underwent vitrectomy. This study looked at one possible explanation for this finding – the presence of outer retinal folds (ORFs). The authors set out to determine whether ORFs in the first month following retinal detachment repair were more common in the vitrectomy group compared to the pneumatic group of the PIVOT trial, and whether ORFs impacted visual acuity results at 1 year.

The authors compared the 1 month postoperative en face and cross-sectional OCT images obtained from subjects in the PIVOT trial with macula-involving retinal detachments. Two independent image graders determined the presence or absence of outer retinal folds, with discrepancies adjudicated by a third grader. Several other ORF characterstics (distance from the fovea, number of folds, angulation of folds, height of folds, total area of folds) were also determined. The primary outcome was the difference in proportion of patients with outer retinal folds at postoperative month 1 in the pneumatic arm versus the vitrectomy arm. Secondary outcomes included the correlation of visual acuity and metamorphopsia scores to the presence of ORFs and a variety of ORF features (distance from the fovea, number of folds, angulation of folds, height of folds, total area of folds).

Of 176 participants in the PIVOT trial, 88 were macula-off at presentation. Of these, 83 had gradable OCT images at the 1 month postoperative visit (41/44 in pars plana vitrectomy [PPV] group, 42/44 in pneumatic group). Baseline characteristics including baseline visual acuity, lens status, age, and gender were not significantly different between groups.

The authors found that 34.1% of patients (14/41) in the vitrectomy group had ORFs at 1 month postintervention versus 14.3% of patients (6/42) in the pneumatic group. This finding was statistically significant (OR = 3.11; 95% CI = 1.06 – 9.15). This difference decreased with time as ORFs resolved in both groups. Mean ETDRS letter scores at 1 year postoperative were also worse in patients with early ORFs compared to those without (65.7 ± 6.6 letters vs 75.1 ± 1.4 letters; 95% CI = 7.5-11.3). Interestingly, the authors found no significant difference in vertical or horizontal metamorphopsia scores between groups. They did, however, find that the vertical metamorphopsia score had a moderate negative correlation with distance from the fovea to the nearest ORF (r = -.507, P=.045). No other ORF characteristic was found to have a statistically significant impact on acuity or metamorphopsia scores.

In order to eliminate the possibility of confounding by treatment group, a subgroup analysis of ETDRS acuity scores in just the vitrectomy group was also performed. This found a similar visual acuity effect. Patients undergoing PPV who had early ORFs were found to have worse acuity than those without (62.8 ± 24.7 vs 75.4 ± 9.2; 95% CI = 0.05 – 24.59).

The authors hypothesize that procedures that quickly drain fluid from the subretinal space do not allow sufficient time for the outer retinal structures to dehydrate prior to apposition between the retina and retinal pigment epithelium cells. They believe this is responsible for the presence of early outer retinal folds which in turn causes worse vision through a variety of mechanisms. This study lends further support to a growing body of literature showing that there may be differences in visual results following retinal detachment repair dependent upon the technique used to repair the detachment. Further study is certainly warranted on this important topic – preferably with larger sample sizes and prospective rather than post-hoc analysis.

Details
  • Overview

    January 2022: VBS Literature Update

    Lee WW, Bansal A, Sadda S, et al. Outer retinal folds following pars plana vitrectomy vs pneumatic retinopexy for retinal detachment repair: post hoc analysis from PIVOT. Ophthalmol Retina. 2021;Sep 11:S2468-6530(21)00284-0. doi: 10.1016/j.oret.2021.09.001. Epub ahead of print. PMID: 34520841.

    Abstract by Christian Sanfilippo, MD

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Compare potential anatomic and functional advantages of using pneumatic retinopexy or vitrectomy to repair macula-involving retinal detachment
    • Accreditation

      Provided by Evolve Medical Education

      Accreditation Statement

      This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education, LLC and Vit Buckle Society.  Evolve Medical Education, LLC is accredited by the ACCME to provide continuing medical education for physicians.

      Credit Designation Statement
      Evolve Medical Education LLC designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • Participation Method

      In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

    • Faculty and Disclosures

      Christian Sanfilippo, MD

      Christian Sanfilippo, MD

      The Retina Partners


      DISCLOSURE POLICY
      It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.

      The following faculty/staff members have the following financial relationships with ineligible companies.

      Christian Sanfilippo, MD, has had a financial agreement or affiliation with the following commercial interests in the form of Consultant: AbbVie.

      The Evolve staff and planners have no financial relationships with commercial interests.
      Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.

    • Disclaimer

      OFF-LABEL STATEMENT
      This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      DISCLAIMER
      The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve.

    • System Requirements

      • Supported Browsers (2 most recent versions):
        • Google Chrome for Windows, Mac OS, iOS, and Android
        • Apple Safari for Mac OS and iOS
        • Mozilla Firefox for Windows, Mac OS, iOS, and Android
        • Microsoft Edge for Windows
      • Recommended Internet Speed: 5Mbps+

    • Publication Dates

      Expiration Date:

    0.50 credits
    Completing the pre-test is required to access this content.
    Completing the pre-survey is required to view this content.

    Ready to Claim Your Credits?

    You have attempts to pass this post-test. Take your time and review carefully before submitting.

    Good luck!

    Register

    We're glad to see you're enjoying Evolve Medical Education…
    but how about a more personalized experience?

    Register for free